Search

Author/Creator Johnson, Parker

1. 568 XTX201, a protein-engineered IL-2, exhibits tumor-selective activity in mice without peripheral toxicities in non-human primates. (9th November 2020)

Authors:
Zhang, Minjie; Guzman, Wilson; Johnson, Parker; McLaughlin, Megan; Jenkins, Kurt; Wu, Hsin-Jung; Madala, Hanumantha Rao; O'Toole, Caitlin; Pederzoli-Ribeil, Magali; Rozenfeld, Raphael; Qiu, Huawei; Karow, Margaret; Clackson, Tim; O'Hagan, Ronan; O'Neil, Jennifer; Eskiocak, Ugur
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A342
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 568 XTX201, a protein-engineered IL-2, exhibits tumor-selective activity in mice without peripheral toxicities in non-human primates. (9th November 2020)

Authors:
Zhang, Minjie; Guzman, Wilson; Johnson, Parker; McLaughlin, Megan; Jenkins, Kurt; Wu, Hsin-Jung; Madala, Hanumantha Rao; O'Toole, Caitlin; Pederzoli-Ribeil, Magali; Rozenfeld, Raphael; Qiu, Huawei; Karow, Margaret; Clackson, Tim; O'Hagan, Ronan; O'Neil, Jennifer; Eskiocak, Ugur
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A602
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 587 Tumor-activated Fc-engineered anti-CTLA-4 monoclonal antibody, XTX101, demonstrates tumor-selective PD and efficacy in preclinical models. (10th December 2020)

Authors:
Jenkins, Kurt; Johnson, Parker; Zhang, Minjie; Guzman, Wilson; Eskiocak, Ugur; McLaughlin, Megan; O'Toole, Caitlin; Pederzoli-Ribeil, Magali; Park, Miso; Williams, John; Karow, Margaret; O'Neil, Jennifer; Clackson, Timothy; O'Hagan, Ronan
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A351
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗